AU2003294396A8 - Tocopherol and tocotrienol medicaments - Google Patents

Tocopherol and tocotrienol medicaments

Info

Publication number
AU2003294396A8
AU2003294396A8 AU2003294396A AU2003294396A AU2003294396A8 AU 2003294396 A8 AU2003294396 A8 AU 2003294396A8 AU 2003294396 A AU2003294396 A AU 2003294396A AU 2003294396 A AU2003294396 A AU 2003294396A AU 2003294396 A8 AU2003294396 A8 AU 2003294396A8
Authority
AU
Australia
Prior art keywords
tocotrienol
tocopherol
medicaments
tocotrienol medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003294396A
Other versions
AU2003294396A1 (en
Inventor
Qing Jiang
Bruce N Ames
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital Oakland Research Center
Original Assignee
Childrens Hospital Oakland Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/301,211 external-priority patent/US20040102421A1/en
Priority claimed from US10/304,918 external-priority patent/US7399784B2/en
Application filed by Childrens Hospital Oakland Research Center filed Critical Childrens Hospital Oakland Research Center
Publication of AU2003294396A8 publication Critical patent/AU2003294396A8/en
Publication of AU2003294396A1 publication Critical patent/AU2003294396A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
AU2003294396A 2002-11-21 2003-11-19 Tocopherol and tocotrienol medicaments Abandoned AU2003294396A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/301,211 2002-11-21
US10/301,211 US20040102421A1 (en) 2002-11-21 2002-11-21 Tocopherol and tocotrienol anti-inflammatory medicaments
US10/304,918 2002-11-26
US10/304,918 US7399784B2 (en) 2002-11-26 2002-11-26 Tocopherol and tocotrienol anti-obesity medicaments
PCT/US2003/037135 WO2004047732A2 (en) 2002-11-21 2003-11-19 Tocopherol and tocotrienol medicaments

Publications (2)

Publication Number Publication Date
AU2003294396A8 true AU2003294396A8 (en) 2004-06-18
AU2003294396A1 AU2003294396A1 (en) 2004-06-18

Family

ID=32396699

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003294396A Abandoned AU2003294396A1 (en) 2002-11-21 2003-11-19 Tocopherol and tocotrienol medicaments

Country Status (2)

Country Link
AU (1) AU2003294396A1 (en)
WO (1) WO2004047732A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715648B2 (en) 2011-02-16 2014-05-06 Pivotal Therapeutics Inc. Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
CN114712514B (en) * 2022-03-03 2023-03-31 浙江大学 Nanometer medicinal preparation for reducing blood fat locally and systemically, and its application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2320807C (en) * 1998-02-11 2011-01-18 Research Triangle Pharmaceuticals Method and composition for treatment of inflammatory conditions
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US20030007961A1 (en) * 2001-06-22 2003-01-09 Wilburn Michael D. Orthomolecular vitamin E derivatives
US7119117B2 (en) * 2001-08-21 2006-10-10 Galileo Pharmaceuticals, Inc. Tocopherol enriched compositions and amelioration of inflammatory symptoms
US20030144219A1 (en) * 2001-11-15 2003-07-31 Phinney Stephen Dodge Formulations and methods for treatment or amelioration of inflammatory conditions

Also Published As

Publication number Publication date
WO2004047732A2 (en) 2004-06-10
AU2003294396A1 (en) 2004-06-18
WO2004047732A3 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
EP1556031A4 (en) Chromones and chromone derivatives and uses thereof
GB0112834D0 (en) Medicaments
AU2002365120A8 (en) Medicaments
IL166058A0 (en) Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof
IL166624A0 (en) Taxane derivatives
HRP20041031A2 (en) Quinolinone derivatives
IL161517A0 (en) 6-hydroxy isoflavones, derivatives and medicaments involving same
AU2003268083A8 (en) Tocopherol biosynthesis related genes and uses thereof
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
GB0206861D0 (en) Medicaments
GB2409645B (en) Flower essence-containing medicaments
GB0102902D0 (en) Medicaments
PL374761A1 (en) N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
AU2003294396A8 (en) Tocopherol and tocotrienol medicaments
AU2002253441A1 (en) Medicaments containing glycerophosphoinositol-4-phosphate derivatives
GB2397817B (en) Coumarin derivatives
EP1499338A4 (en) 7-hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof
GB0115182D0 (en) Medicaments
GB0225206D0 (en) Medicaments
GB0215395D0 (en) Medicaments
GB0219241D0 (en) Medicaments
AU2003204974A1 (en) Anti-dampness chest protector for babies
GB0130679D0 (en) Medicaments and novel compounds
GB0130785D0 (en) Medicaments and novel compounds
GB0130678D0 (en) Medicaments and novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase